Role of ITPA and SLC28A2 genes in the prediction of anaemia associated with protease inhibitor plus ribavirin and peginterferon in hepatitis C treatment-Reference-Cited by-同舟云学术

Role of ITPA and SLC28A2 genes in the prediction of anaemia associated with protease inhibitor plus ribavirin and peginterferon in hepatitis C treatment

Published:2015-07 Issue: Volume:68 Page:56-60
ISSN:1386-6532
Container-title:Journal of Clinical Virology
language:en
Short-container-title:Journal of Clinical Virology

Author:

Ampuero Javier,Del Campo José Antonio,Rojas Lourdes,Calleja José Luis,Cabezas Joaquín,Lens Sabela,Crespo Javier,Forns Xavier,Andrade Raúl J.,Fernández Inmaculada,Buti María,Millán Raquel,Romero-Gómez Manuel

Funder

Spanish Ministry of Economy, Innovation and Competition

Publisher

Elsevier BV

Subject

Infectious Diseases,Virology

Reference29 articles.

1. Peginterferon alfa 2b and weight-based flat dose ribavirin in chronic hepatitis C patients: a randomized trial;Jacobson;Hepatology,2007

2. Management of anemia induced by triple therapy in patients with chronic hepatitis C: challenges: opportunities and recommendations;Romero-Gomez;J. Hepatol.,2013

3. Risk factors predictive of anemia development during telaprevir plus peginterferon/ribavirin therapy in treatment-experienced patients;Zeuzem;J. Hepatol.,2014

4. Significant early higher ribavirin plasma concentrations in patients receiving a triple therapy with pegylated interferon, ribavirin and telaprevir;Boglione;J. Viral Hepatitis,2014

5. ITPA gene variants protect against anaemia in patients treated forchronic hepatitis C;Fellay;Nature,2010

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of ITPA gene polymorphism for predicting anemia and treatment outcome in HCV infected patients taking Sofosbuvir Ribavirin therapy;BMC Infectious Diseases;2024-03-11

2. Identification of hub genes and key pathways in pediatric Crohn’s disease using next generation sequencing and bioinformatics analysis;2022-07-28

3. Novel variant in glycophorin c gene protects against ribavirin-induced anemia during chronic hepatitis C treatment;Biomedicine & Pharmacotherapy;2021-11

4. Association between inosine triphosphatase rs1127354 polymorphisms and ribavirin‐induced anaemia and outcome in hepatitis C virus‐infected patients: A meta‐analysis;Journal of Clinical Pharmacy and Therapeutics;2020-07-31

5. The genetic landscape of the human solute carrier (SLC) transporter superfamily;Human Genetics;2019-11-02